JANA Partners 13F holdings, Q1 2021
Holdings as of March 31, 2021 · filings on SEC EDGAR · latest filing →
JANA Partners disclosed 8 US equity positions worth $1.5bn in its Q1 2021 13F filing. The largest position was CAG at 27.5% of the reported book, followed by LABORATORY CORP AMER HLDGS and PRSP. Against the Q4 2020 filing, it opened 2 new positions, added to 2 and reduced 3 among the top 8 holdings.
What did JANA Partners own in Q1 2021? Top 8 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2020 |
|---|---|---|---|---|---|---|---|
| 1 | CAG CONAGRA BRANDS INC | Consumer Defensive | 27.5% | $408.3m | 10,858,403 | 0% | held |
| 2 | LABORATORY CORP AMER HLDGS | 19.6% | $290.6m | 1,139,588 | 40% | added | |
| 3 | PRSP PERSPECTA INC | 15.3% | $226.6m | 7,800,242 | -49% | reduced | |
| 4 | THS TREEHOUSE FOODS INC | 14.6% | $216.9m | 4,152,910 | 104% | added | |
| 5 | EHC ENCOMPASS HEALTH CORP | Healthcare | 9.4% | $139.5m | 1,703,260 | -34% | reduced |
| 6 | SPY SPDR S&P 500 ETF TR | 6.4% | $95.3m | 240,347 | -13% | reduced | |
| 7 | VONAGE HLDGS CORP | 4.6% | $68.6m | 5,803,478 | – | new | |
| 8 | CYRUSONE INC | 2.5% | $37.3m | 551,365 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.